News | RIVM

RIVM magazine special edition on Climate Change and Health

The RIVM Magazine special edition on Climate change and Health showcases the scope of RIVM’s work on this topic.

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Spread of tick-borne encephalitis virus in the Netherlands

Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

New test has no added value in Lyme disease of the central nervous system

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.

Lyme disease costs EUR 20 million annually

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.

Step forward in the battle against pertussis

Addition of an extra adjuvant (additive) to the current pertussis vaccines could enhance the effectivity of these vaccines.

Lab tests alone not conclusive for diagnosis of Lyme disease

Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.

Major loss of healthy life years due to long-term complaints after Lyme disease

The Netherlands is the first country where the burden of disease due to Lyme disease has been determined.